Objective: To evaluate the seroprevalence of positive markers for syphilis, human immunodeficiency virus (HIV) I and II, human T cell lymphotropic virus (HTLV) I and II, and hepatitis B and C among women undergoing in vitro fertilization (IVF).
Methods: We conducted a retrospective analysis among patients who underwent IVF, between January 2013 and February 2016, and who had complete screening records.
Results: We analyzed 1,008 patients who underwent IVF, amounting to 2,445 cycles.
Rev Bras Ginecol Obstet
March 2019